Candidate oncogenes and current literature.

Genes were selected as follows: Gain in >40% and differentially expressed, with fold change expression in gain vs. neutral of >0.7 or correlation coefficient (r) of >0.7. Of these genes (n = 121), the most frequently gained in each chromosome were selected: Chr 3 n≥50, Chr8 n≥60, Chr 20 n≥42. 2. High level amplification in at least 5 samples (*), and differentially expressed, with fold change expression in gain vs. neutral of >0.6 or correlation coefficient (r) of >0.6. Chr19 genes (n = 12) are not shown here.